Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease

Area of Science:

• Immunology
• Pathology

Background:

• Serum amyloid P component (SAP) is an acute-phase reactant.
• Previous studies suggested SAP-deficient mice develop autoimmune disease and glomerulonephritis.
• SAP is known to bind lipopolysaccharide (LPS) and modulate complement activation.

Purpose of the Study:

• To investigate autoimmune responses in SAP-deficient mice generated in-house.
• To determine the role of SAP in LPS-induced toxicity.

Main Methods:

• Generated and phenotypically analyzed SAP-deficient mice.
• Assessed autoantibody production and glomerulonephritis development.
• Administered Salmonella typhimirium LPS intraperitoneally to assess survival.

Main Results:

• SAP-deficient mice produced anti-nuclear antibodies but did not develop severe glomerulonephritis.
• SAP-deficient mice exhibited resistance to lethal effects of high-dose LPS.
• Findings contradict previous reports on SAP deficiency-induced autoimmune disease.

Conclusions:

• SAP deficiency does not appear to cause severe autoimmune disease in mice.
• SAP plays a critical role in the toxicity of LPS.
• Further research is warranted to elucidate SAP's role in immune responses and LPS toxicity.